Bodal Chemicals Q2/H1 FY26 PAT jumps, helped by unit sale gains and insurance claim

Profit growth above 25%Exceptional itemResults View source PDF Explain this filing

BODALCHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.5%Reaction day

₹59.75

prior close

₹59.84

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.9%-3.5% vs market

On the reaction day the stock moved 3.5 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.3

10m

-0.9

15m

-1.2

30m

-0.8

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-2.5+0.9-3.5

Next day

-3.7+0.8-4.6

-3.1+0.7-3.8

-4.7+1.3-6.1

-6.0+0.5-6.5

-6.6+0.4-7.0

-8.8-1.5-7.3

15d

-12.1-2.4-9.7

-11.3-4.4-6.9

-12.6-7.2-5.4

-13.9-5.0-8.9

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Bodal Chemicals Q2 FY26 consolidated revenue rose 11% year-on-year to Rs 480.45 crore; H1 revenue at Rs 934.66 crore, up 9%. PAT jumped sharply to Rs 5.99 crore in Q2 and Rs 15.53 crore for H1 versus about Rs 0.99 crore last year. Profits were lifted by Rs 17.89 crore from sale of closed Units II and III and a Rs 4.71 crore insurance payout for a prior fire at Unit 7. An exceptional Rs 30 lakh fire loss was booked. Results include hyperinflation adjustments for the Turkish subsidiary.

Likely market impact

Strong profit growth driven mainly by one-time asset sale gains; underlying operating performance was modest with finance costs near Rs 20 crore a quarter.